ILDONG PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,660 KRW | +0.13% |
|
+0.64% | -13.77% |
| 2023 | Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea | MT |
| 2023 | Il Dong Pharmaceutical Introduces New R&D Unit Yunovia | MT |
ETFs positioned on Ildong Pharmaceutical Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 0 M€ | +4.02% | - | |
| 0.00% | 4 M€ | -4.41% | - |
IL DONG PHARMACEUTICAL CO., LTD. is a Korea-based company mainly engaged in the manufacture of pharmaceuticals.
Sector
Pharmaceuticals
Calendar
13/05/2024
- Q1 2024 Earnings Release (Projected)
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.77% | 320M | |
| +32.36% | 695B | |
| +26.51% | 568B | |
| -4.40% | 361B | |
| +19.46% | 330B | |
| +3.50% | 283B | |
| +16.34% | 239B | |
| +6.68% | 204B | |
| -9.08% | 198B | |
| +8.62% | 168B |
- Stock Market
- Equities
- A249420 Stock
- Funds and ETFs Ildong Pharmaceutical Co., Ltd.